From the Strategy and Health areas of SILO we are accompanying the authorities responsible for the PERTE for Vanguard Health in its mid-term evaluation, which will be presented soon. This process seeks to value the impact of PERTE in the ecosystem of R&D&I in health in our country.
As part of this accompaniment, we have conducted interviews with key players in the ecosystem and dynamized the session “The future of R&D&I in health as a lever for health, economic and industrial transformation in Spain”. In this process, shared with the working group – made up of representatives of the General State Administration, autonomous communities, business associations, patients’ associations and third-sector entities – the main challenges and opportunities of the healthcare R&D&I system were identified.
During the session, the strategic objectives, cross-cutting lines of action and priority areas of investment that will guide the next steps of PERTE for Vanguard Health were also presented.